Hualan Biological Bacterin Inc. Posted 298.2 Million Yuan Net Profit in First Half of 2022

Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 298.2 million yuan in the first half of 2022, reversing a net loss of 29 million yuan for the same period in the previous year.

Meanwhile, the company posted 1.1 billion yuan in revenue, up 9624.8% year-on-year.

At the end of the reporting period, it had 7.3 billion yuan in total assets and 2 billion yuan in total liabilities, with a liability-to-asset ratio of 27.5%.